Compare Cassava Sciences Inc (FLNA) vs PayPal Holdings, Inc. (PYPL) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

PayPal (PYPL) surged 20.24% to $56.96 following a $53 billion takeover bid from Stripe and Advent International at $60.50 per share. The stock trades near resistance at $57 with RSI indicating overbought conditions. Fundamentally, PYPL shows strong profitability with a 15% net income margin and attractive valuation at a P/E of 10.42. Recent earnings beat expectations in Q1 2026 with EPS of $1.34 versus $1.27 forecast.

The acquisition offer creates near-term upside potential, though regulatory approval risks remain. Long-term investors face competition in digital payments and execution challenges. Analyst consensus is mixed with a $49.50 price target below current levels, suggesting caution despite bullish technical momentum.